Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2017

Open Access 01-12-2017 | Research

4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease

Authors: Kim-Lien Nguyen, Fei Han, Ziwu Zhou, Daniel Z. Brunengraber, Ihab Ayad, Daniel S. Levi, Gary M. Satou, Brian L. Reemtsen, Peng Hu, J. Paul Finn

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2017

Login to get access

Abstract

Background

4D Multiphase Steady State Imaging with Contrast (MUSIC) acquires high-resolution volumetric images of the beating heart during uninterrupted ventilation. We aim to evaluate the diagnostic performance and clinical impact of 4D MUSIC in a cohort of neonates and infants with congenital heart disease (CHD).

Methods

Forty consecutive neonates and infants with CHD (age range 2 days to 2 years, weight 1 to 13 kg) underwent 3.0 T CMR with ferumoxytol enhancement (FE) at a single institution. Independently, two readers graded the diagnostic image quality of intra-cardiac structures and related vascular segments on FE-MUSIC and breath held FE-CMRA images using a four-point scale. Correlation of the CMR findings with surgery and other imaging modalities was performed in all patients. Clinical impact was evaluated in consensus with referring surgeons and cardiologists. One point was given for each of five key outcome measures: 1) change in overall management, 2) change in surgical approach, 3) reduction in the need for diagnostic catheterization, 4) improved assessment of risk-to-benefit for planned intervention and discussion with parents, 5) accurate pre-procedural roadmap.

Results

All FE-CMR studies were completed successfully, safely and without adverse events. On a four-point scale, the average FE-MUSIC image quality scores were >3.5 for intra-cardiac structures and >3.0 for coronary arteries. Intra-cardiac morphology and vascular anatomy were well visualized with good interobserver agreement (r = 0.46). Correspondence between the findings on MUSIC, surgery, correlative imaging and autopsy was excellent. The average clinical impact score was 4.2 ± 0.9. In five patients with discordant findings on echo/MUSIC (n = 5) and catheter angiography/MUSIC (n = 1), findings on FE-MUSIC were shown to be accurate at autopsy (n = 1) and surgery (n = 4). The decision to undertake biventricular vs univentricular repair was amended in 2 patients based on FE-MUSIC findings. Plans for surgical approaches which would have involved circulatory arrest were amended in two of 28 surgical cases. In all 28 cases requiring procedural intervention, FE-MUSIC provided accurate dynamic 3D roadmaps and more confident risk-to-benefit assessments for proposed interventions.

Conclusions

FE-MUSIC CMR has high clinical impact by providing accurate, high quality, simple and safe dynamic 3D imaging of cardiac and vascular anatomy in neonates and infants with CHD. The findings influenced patient management in a positive manner.
Appendix
Available only for authorised users
Literature
1.
go back to reference Han F, Rapacchi S, Khan S, Ayad I, Salusky I, Gabriel S, Plotnik A, Finn JP, Hu P. Four-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart: A feasibility study in children. Magn Reson Med. 2015;74:1042–9.CrossRefPubMed Han F, Rapacchi S, Khan S, Ayad I, Salusky I, Gabriel S, Plotnik A, Finn JP, Hu P. Four-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart: A feasibility study in children. Magn Reson Med. 2015;74:1042–9.CrossRefPubMed
2.
go back to reference Saleh RS, Patel S, Lee MH, Boechat MI, Ratib O, Saraiva CR, Finn JP. Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children. Radiology. 2007;243:837–46.CrossRefPubMed Saleh RS, Patel S, Lee MH, Boechat MI, Ratib O, Saraiva CR, Finn JP. Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children. Radiology. 2007;243:837–46.CrossRefPubMed
3.
go back to reference Tsai-Goodman B, Geva T, Odegard KC, Sena LM, Powell AJ. Clinical role, accuracy, and technical aspects of cardiovascular magnetic resonance imaging in infants. Am J Cardiol. 2004;94:69–74.CrossRefPubMed Tsai-Goodman B, Geva T, Odegard KC, Sena LM, Powell AJ. Clinical role, accuracy, and technical aspects of cardiovascular magnetic resonance imaging in infants. Am J Cardiol. 2004;94:69–74.CrossRefPubMed
4.
go back to reference Nguyen KL, Khan SN, Moriarty JM, Mohajer K, Renella P, Satou G, Ayad I, Patel S, Boechat MI, Finn JP. High-field MR imaging in pediatric congenital heart disease: Initial results. Pediatr Radiol. 2015;45:42–54.CrossRefPubMed Nguyen KL, Khan SN, Moriarty JM, Mohajer K, Renella P, Satou G, Ayad I, Patel S, Boechat MI, Finn JP. High-field MR imaging in pediatric congenital heart disease: Initial results. Pediatr Radiol. 2015;45:42–54.CrossRefPubMed
5.
go back to reference Li W, Tutton S, Vu AT, Pierchala L, Li BS, Lewis JM, Prasad PV, Edelman RR. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J Magn Reson Imaging. 2005;21:46–52.CrossRefPubMed Li W, Tutton S, Vu AT, Pierchala L, Li BS, Lewis JM, Prasad PV, Edelman RR. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J Magn Reson Imaging. 2005;21:46–52.CrossRefPubMed
7.
go back to reference Han F, Zhou Z, Han E, Gao Y, Nguyen KL, Finn JP, Hu P. Self-gated 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) using rotating cartesian K-space (ROCK): Validation in children with congenital heart disease. Magn Reson Med. 2016. doi:10.1002/mrm.26376 [Epub ahead of print]. Han F, Zhou Z, Han E, Gao Y, Nguyen KL, Finn JP, Hu P. Self-gated 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) using rotating cartesian K-space (ROCK): Validation in children with congenital heart disease. Magn Reson Med. 2016. doi:10.​1002/​mrm.​26376 [Epub ahead of print].
8.
go back to reference Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging. 2007;26:375–85.CrossRefPubMed Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging. 2007;26:375–85.CrossRefPubMed
10.
go back to reference Arpasi PJ, Bis KG, Shetty AN, White RD, Simonetti OP. MR angiography of the thoracic aorta with an electrocardiographically triggered breath-hold contrast-enhanced sequence. Radiographics. 2000;20:107–20.CrossRefPubMed Arpasi PJ, Bis KG, Shetty AN, White RD, Simonetti OP. MR angiography of the thoracic aorta with an electrocardiographically triggered breath-hold contrast-enhanced sequence. Radiographics. 2000;20:107–20.CrossRefPubMed
11.
go back to reference Groves EM, Bireley W, Dill K, Carroll TJ, Carr JC. Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol. 2007;188:522–8.CrossRefPubMed Groves EM, Bireley W, Dill K, Carroll TJ, Carr JC. Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol. 2007;188:522–8.CrossRefPubMed
12.
go back to reference Sorensen TS, Korperich H, Greil GF, Eichhorn J, Barth P, Meyer H, Pedersen EM, Beerbaum P. Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation. 2004;110:163–9.CrossRefPubMed Sorensen TS, Korperich H, Greil GF, Eichhorn J, Barth P, Meyer H, Pedersen EM, Beerbaum P. Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation. 2004;110:163–9.CrossRefPubMed
13.
go back to reference Fenchel M, Greil GF, Martirosian P, Kramer U, Schick F, Claussen CD, Sieverding L, Miller S. Three-dimensional morphological magnetic resonance imaging in infants and children with congenital heart disease. Pediatr Radiol. 2006;36:1265–72.CrossRefPubMed Fenchel M, Greil GF, Martirosian P, Kramer U, Schick F, Claussen CD, Sieverding L, Miller S. Three-dimensional morphological magnetic resonance imaging in infants and children with congenital heart disease. Pediatr Radiol. 2006;36:1265–72.CrossRefPubMed
14.
go back to reference Seeger A, Fenchel MC, Greil GF, Martirosian P, Kramer U, Bretschneider C, Doering J, Claussen CD, Sieverding L, Miller S. Three-dimensional cine MRI in free-breathing infants and children with congenital heart disease. Pediatr Radiol. 2009;39:1333–42.CrossRefPubMed Seeger A, Fenchel MC, Greil GF, Martirosian P, Kramer U, Bretschneider C, Doering J, Claussen CD, Sieverding L, Miller S. Three-dimensional cine MRI in free-breathing infants and children with congenital heart disease. Pediatr Radiol. 2009;39:1333–42.CrossRefPubMed
16.
go back to reference Febbo JA, Galizia MS, Murphy IG, Popescu A, Bi X, Turin A, Collins J, Markl M, Edelman RR, Carr JC. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA. Eur J Radiol. 2015;84:1921–9.CrossRefPubMed Febbo JA, Galizia MS, Murphy IG, Popescu A, Bi X, Turin A, Collins J, Markl M, Edelman RR, Carr JC. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA. Eur J Radiol. 2015;84:1921–9.CrossRefPubMed
17.
go back to reference Markl M, Kilner PJ, Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:7.CrossRefPubMedPubMedCentral Markl M, Kilner PJ, Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:7.CrossRefPubMedPubMedCentral
18.
go back to reference Cheng JY, Hanneman K, Zhang T, Alley MT, Lai P, Tamir JI, Uecker M, Pauly JM, Lustig M, Vasanawala SS. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease. J Magn Reson Imaging. 2016;43(6):1355–68.CrossRefPubMed Cheng JY, Hanneman K, Zhang T, Alley MT, Lai P, Tamir JI, Uecker M, Pauly JM, Lustig M, Vasanawala SS. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease. J Magn Reson Imaging. 2016;43(6):1355–68.CrossRefPubMed
19.
go back to reference Lai LM, Cheng JY, Alley MT, Zhang T, Lustig M and Vasanawala SS. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia. J Magn Reson Imaging. 2016 Sep 28. doi:10.1002/jmri.25482. Lai LM, Cheng JY, Alley MT, Zhang T, Lustig M and Vasanawala SS. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia. J Magn Reson Imaging. 2016 Sep 28. doi:10.​1002/​jmri.​25482.
20.
go back to reference AMAG Pharmaceuticals. Feraheme Drug Label. 2014. (revised March 2015); April 2015. AMAG Pharmaceuticals. Feraheme Drug Label. 2014. (revised March 2015); April 2015.
21.
go back to reference Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 2015;41:884–98.CrossRefPubMed Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 2015;41:884–98.CrossRefPubMed
22.
go back to reference Finn JP, Nguyen KL, Han F, Zhou Z, Salusky I, Ayad I, Hu P. Cardiovascular MRI with ferumoxytol. Clin Radiol. 2016;71:796–806.CrossRefPubMed Finn JP, Nguyen KL, Han F, Zhou Z, Salusky I, Ayad I, Hu P. Cardiovascular MRI with ferumoxytol. Clin Radiol. 2016;71:796–806.CrossRefPubMed
23.
go back to reference Bashir MR, Jaffe TA, Brennan TV, Patel UD, Ellis MJ. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. Transplantation. 2013;96:91.CrossRefPubMed Bashir MR, Jaffe TA, Brennan TV, Patel UD, Ellis MJ. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. Transplantation. 2013;96:91.CrossRefPubMed
24.
go back to reference Prince MR, Zhang HL, Chabra SG, Jacobs P, Wang Y. A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI. J Xray Sci Technol. 2003;11:231–40.PubMed Prince MR, Zhang HL, Chabra SG, Jacobs P, Wang Y. A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI. J Xray Sci Technol. 2003;11:231–40.PubMed
25.
go back to reference Nayak AB, Luhar A, Hanudel M, Gales B, Hall TR, Finn JP, Salusky IB, Zaritsky J. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort. Pediatr Nephrol. 2015;30:515–21.CrossRefPubMed Nayak AB, Luhar A, Hanudel M, Gales B, Hall TR, Finn JP, Salusky IB, Zaritsky J. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort. Pediatr Nephrol. 2015;30:515–21.CrossRefPubMed
26.
go back to reference Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 2009;75:465–74.CrossRefPubMed Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 2009;75:465–74.CrossRefPubMed
27.
go back to reference Bashir MR, Mody R, Neville A, Javan R, Seaman D, Kim CY, Gupta RT, Jaffe TA. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. J Magn Reson Imaging. 2014;40:113–8.CrossRefPubMed Bashir MR, Mody R, Neville A, Javan R, Seaman D, Kim CY, Gupta RT, Jaffe TA. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. J Magn Reson Imaging. 2014;40:113–8.CrossRefPubMed
28.
go back to reference Walker JP, Nosova E, Sigovan M, Rapp J, Grenon MS, Owens CD, Gasper WJ, Saloner DA. Ferumoxytol-Enhanced Magnetic Resonance Angiography is a Feasible Method for the Clinical Evaluation of Lower Extremity Arterial Disease. Ann Vasc Surg. 2015;29:63–8.CrossRefPubMed Walker JP, Nosova E, Sigovan M, Rapp J, Grenon MS, Owens CD, Gasper WJ, Saloner DA. Ferumoxytol-Enhanced Magnetic Resonance Angiography is a Feasible Method for the Clinical Evaluation of Lower Extremity Arterial Disease. Ann Vasc Surg. 2015;29:63–8.CrossRefPubMed
29.
go back to reference McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275:772–82.CrossRefPubMed McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275:772–82.CrossRefPubMed
30.
go back to reference Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907–16.CrossRefPubMed Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907–16.CrossRefPubMed
31.
go back to reference Nguyen KL, Yoshida T, Han F, Ayad I, Reemtsen BL, Salusky IB, Satou GM, Hu P, Finn JP. MRI with Ferumoxytol: A Single Center Experience of Safety Across the Age Spectrum. J Magn Reson. 2017;45(3):804-812. Nguyen KL, Yoshida T, Han F, Ayad I, Reemtsen BL, Salusky IB, Satou GM, Hu P, Finn JP. MRI with Ferumoxytol: A Single Center Experience of Safety Across the Age Spectrum. J Magn Reson. 2017;45(3):804-812.
32.
go back to reference Ning P, Zucker EJ, Wong P, Vasanawala SS. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults. Magn Reson Imaging. 2016;34:152–8.CrossRefPubMed Ning P, Zucker EJ, Wong P, Vasanawala SS. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults. Magn Reson Imaging. 2016;34:152–8.CrossRefPubMed
33.
go back to reference Muehe AM, Feng D, Von Eyben R, Luna-Fineman S, Link MP, Muthig T, Huddleston AE, Neuwelt EA, Daldrup-Link HE. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults. Invest Radiol. 2016;51:221–7.CrossRefPubMed Muehe AM, Feng D, Von Eyben R, Luna-Fineman S, Link MP, Muthig T, Huddleston AE, Neuwelt EA, Daldrup-Link HE. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults. Invest Radiol. 2016;51:221–7.CrossRefPubMed
34.
go back to reference Elzouki AY HH, Nazer HM, Stapleton FB, Oh W, Whitley RJ. Textbook of Clinical Pediatrics. 2nd ed. New York: Springer; 2012.CrossRef Elzouki AY HH, Nazer HM, Stapleton FB, Oh W, Whitley RJ. Textbook of Clinical Pediatrics. 2nd ed. New York: Springer; 2012.CrossRef
35.
36.
go back to reference Gervassi AL, Horton H. Is Infant Immunity Actively Suppressed or Immature? Virol. 2014;2014:1–9. Gervassi AL, Horton H. Is Infant Immunity Actively Suppressed or Immature? Virol. 2014;2014:1–9.
Metadata
Title
4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease
Authors
Kim-Lien Nguyen
Fei Han
Ziwu Zhou
Daniel Z. Brunengraber
Ihab Ayad
Daniel S. Levi
Gary M. Satou
Brian L. Reemtsen
Peng Hu
J. Paul Finn
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2017
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/s12968-017-0352-8

Other articles of this Issue 1/2017

Journal of Cardiovascular Magnetic Resonance 1/2017 Go to the issue